KPTI Karyopharm Therapeutics Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
15:58
Sep 08
Sep 08
r/smallstreetbets
KPTI dilution risk despite high short interest
Author had Karyopharm at $2.04, now $1.79 and still hasn't worked. $41M cap vs ~$65M liquidity, 54% short but only ~7 months runway. Very possible to be right on the drug and still get diluted before getting paid.
KPTI
Karyopharm Therapeutics Inc.
Avoid
—
—
17:39
Feb 05
Feb 05
r/biotech_stocks
KPTI myelofibrosis readout skews negative due endpoint difficulty
The author believes Karyopharm's myelofibrosis readout will likely be negative because the composite endpoint is difficult to hit, noting that Novartis's pelabresib failed on the same endpoint. Selinexor's history of toxicity also forms part of the endpoint, adding risk. The author is more bullish on an endometrial cancer trial but worries the company may face bankruptcy before that data reads out.
KPTI
Karyopharm Therapeutics Inc.
Avoid
—
—
About KPTI Investor Commentary
Across the available history and selected sources, Buzzberg tracks KPTI (Karyopharm Therapeutics Inc.) across 3 sources: 0 bullish vs 0 bearish calls from 3 authors. Historical directional balance: 0% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 3 total trade ideas tracked. Latest voices: u/Avish_Golakiya, u/elchicharito1322.